Skip to main content

A multi-institutional evaluation of the safety and efficacy of bevacizumab for recurrent, platinum-resistant ovarian cancer.

Publication ,  Conference
WriQht, JD; Alvarezsecord, A; Numnum, TM; Rocconi, RP; Powell, MA; Berchuck, A; Alvarez, RD; Trinkaus, K; Rader, JS; Mutch, DG
Published in: JOURNAL OF CLINICAL ONCOLOGY
June 20, 2006

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

ISSN

0732-183X

Publication Date

June 20, 2006

Volume

24

Issue

18

Start / End Page

260S / 260S

Location

Atlanta, GA

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

42nd Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
WriQht, J. D., Alvarezsecord, A., Numnum, T. M., Rocconi, R. P., Powell, M. A., Berchuck, A., … Mutch, D. G. (2006). A multi-institutional evaluation of the safety and efficacy of bevacizumab for recurrent, platinum-resistant ovarian cancer. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 24, pp. 260S-260S). Atlanta, GA: AMER SOC CLINICAL ONCOLOGY.
WriQht, J. D., A. Alvarezsecord, T. M. Numnum, R. P. Rocconi, M. A. Powell, A. Berchuck, R. D. Alvarez, K. Trinkaus, J. S. Rader, and D. G. Mutch. “A multi-institutional evaluation of the safety and efficacy of bevacizumab for recurrent, platinum-resistant ovarian cancer.” In JOURNAL OF CLINICAL ONCOLOGY, 24:260S-260S. AMER SOC CLINICAL ONCOLOGY, 2006.
WriQht JD, Alvarezsecord A, Numnum TM, Rocconi RP, Powell MA, Berchuck A, et al. A multi-institutional evaluation of the safety and efficacy of bevacizumab for recurrent, platinum-resistant ovarian cancer. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2006. p. 260S-260S.
WriQht, J. D., et al. “A multi-institutional evaluation of the safety and efficacy of bevacizumab for recurrent, platinum-resistant ovarian cancer.JOURNAL OF CLINICAL ONCOLOGY, vol. 24, no. 18, AMER SOC CLINICAL ONCOLOGY, 2006, pp. 260S-260S.
WriQht JD, Alvarezsecord A, Numnum TM, Rocconi RP, Powell MA, Berchuck A, Alvarez RD, Trinkaus K, Rader JS, Mutch DG. A multi-institutional evaluation of the safety and efficacy of bevacizumab for recurrent, platinum-resistant ovarian cancer. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2006. p. 260S-260S.

Published In

JOURNAL OF CLINICAL ONCOLOGY

ISSN

0732-183X

Publication Date

June 20, 2006

Volume

24

Issue

18

Start / End Page

260S / 260S

Location

Atlanta, GA

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

42nd Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences